Background: The European Medical Devices Regulation (MDR) 2017/745 seeks to minimize clinical uncertainty – especially regarding the generation, dissemination, and quality of clinical evidence – across all phases of the medical device lifecycle: pre-market, market approval, post-market, and disinvestment. Although the MDR promotes using gold-standard methodologies, such as Randomized Controlled Trials to address clinical uncertainty, [...]